We are live on ! Find out more
EntryPoint Capital

EntryPoint Capital Portfolio holdings

AUM $365M Turnover 57.12%
1-Year Est. Return 16.27%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+16.27%
3 Year Est. Return
+40.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
4.92%
Holding
1,330
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 18.72%
2 Technology 15.99%
3 Industrials 14.9%
4 Financials 13.46%
5 Consumer Discretionary 12.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IHRT icon
1
iHeartMedia
IHRT
$69.6M
$710K 0.68%
265,778
– –
2023 Q4
0 quarters
NEXT icon
2
NextDecade
NEXT
$1.54B
$553K 0.53%
116,026
– –
2023 Q4
0 quarters
AMWL icon
3
American Well
AMWL
$185M
$535K 0.51%
17,955
– –
2023 Q4
0 quarters
RILY icon
4
BRC Group Holdings
RILY
$113M
$526K 0.5%
25,051
– –
2023 Q4
0 quarters
TSHA icon
5
Taysha Gene Therapies
TSHA
$1.21B
$516K 0.49%
291,616
– –
2023 Q4
0 quarters
LXRX icon
6
Lexicon Pharmaceuticals
LXRX
$681M
$496K 0.48%
323,968
– –
2023 Q4
0 quarters
ATLX icon
7
Atlas Lithium
ATLX
$42M
$463K 0.44%
14,799
– –
2023 Q4
0 quarters
APPN icon
8
Appian
APPN
$3.7B
$449K 0.43%
11,934
– –
2023 Q4
0 quarters
ANIP icon
9
ANI Pharmaceuticals
ANIP
$1.56B
$444K 0.43%
8,052
– –
2023 Q4
0 quarters
CMPS icon
10
Compass Pathways
CMPS
$1.14B
$437K 0.42%
49,959
– –
2023 Q4
0 quarters
UP icon
11
Wheels Up
UP
$62.2M
$397K 0.38%
5,789
– –
2023 Q4
0 quarters
ERII icon
12
Energy Recovery
ERII
$328M
$364K 0.35%
19,346
– –
2023 Q4
0 quarters
FOR icon
13
Forestar Group
FOR
$1.13B
$347K 0.33%
10,489
– –
2023 Q4
0 quarters
NXDR icon
14
Nextdoor Holdings
NXDR
$727M
$343K 0.33%
181,327
– –
2023 Q4
0 quarters
BWB icon
15
Bridgewater Bancshares
BWB
$566M
$339K 0.32%
25,070
– –
2023 Q4
0 quarters
BCYC icon
16
Bicycle Therapeutics
BCYC
$203M
$334K 0.32%
18,495
– –
2023 Q4
0 quarters
XNCR icon
17
Xencor
XNCR
$2.5B
$327K 0.31%
15,419
– –
2023 Q4
0 quarters
GPCR icon
18
Structure Therapeutics
GPCR
$1.15B
$319K 0.31%
7,835
– –
2023 Q4
0 quarters
AHCO icon
19
AdaptHealth
AHCO
$983M
$317K 0.3%
43,480
– –
2023 Q4
0 quarters
ACCO icon
20
Acco Brands
ACCO
$498M
$317K 0.3%
52,075
– –
2023 Q4
0 quarters
PLPC icon
21
Preformed Line Products
PLPC
$1.2B
$316K 0.3%
2,361
– –
2023 Q4
0 quarters
PRME icon
22
Prime Medicine
PRME
$792M
$312K 0.3%
35,235
– –
2023 Q4
0 quarters
CNDT icon
23
Conduent
CNDT
$136M
$307K 0.29%
84,208
– –
2023 Q4
0 quarters
TRS icon
24
TriMas
TRS
$1.3B
$306K 0.29%
12,092
– –
2023 Q4
0 quarters
EB icon
25
DELISTED
Eventbrite
EB
$306K 0.29%
36,552
– –
2023 Q4
0 quarters

Similar funds

EntryPoint Capital's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for EntryPoint Capital, which disclosed 1,330 positions worth $104M. Its ten largest holdings account for 4.9% of the portfolio.

Its largest position is iHeartMedia: 265,778 shares worth $710K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Industrials.

  • EntryPoint Capital's ten largest holdings make up 4.9% of its $104M portfolio in Q4 2023.
  • EntryPoint Capital disclosed 1,330 positions in Q4 2023, its first 13F filing on record.

Based on EntryPoint Capital's 13F filing for Q4 2023, filed 14 Feb 2024.